Durvalumab with cisplatin and etoposide
WebCisplatin 75-80 1 Q3W 4 Etoposide 100 1-3 Q3W 4 Durvalumab 1500 mg 1 Q4W maintenance 藥品名 劑量 mg/m2 給藥日 頻率 週期 參考文獻 Durvalumab 1500 mg 1 Q3W 4 10 Carboplatin AUC 5-6 1 Q3W 4 Etoposide 100 1-3 Q3W 4 Durvalumab 1500 mg 1 Q4W maintenance 藥品名 劑量 mg/m2 給藥日 頻率 週期 參考文獻 Cisplatin 75-80 1 … WebApr 11, 2024 · Two phase 3 trials evaluated the addition of programmed cell death-ligand 1 (PD-L1) inhibitor atezolizumab (IMpower133) (5, 6) or durvalumab (CASPIAN) (7, 8) to …
Durvalumab with cisplatin and etoposide
Did you know?
WebMar 1, 2024 · Experimental: Durvalumab - (cisplatin or carboplatin) - Etoposide Participants will receive durvalumab dose A administered via intravenous (IV) … WebIn combination with etoposide and either carboplatin or cisplatin, ... (268 to durvalumab plus tremelimumab plus platinum–etoposide, 268 to durvalumab plus platinum–etoposide, and 269 to platinum–etoposide). As of Jan 27, 2024, the median follow-up was 25·1 months (IQR 22·3–27·9). ...
WebMay 25, 2024 · Background: In extensive stage small-cell lung cancer (ES-SCLC) immune check-point inhibitors, atezolizumab and durvalumab, when combined with … WebFeb 6, 2024 · Patients were randomized in a 1:1:1 ratio to receive treatment with durvalumab + tremelimumab + etoposide and platinum-based chemotherapy (EP), durvalumab + EP or EP alone. 987 participants were randomized in the study overall. ... (80-100 mg/m^2) with either carboplatin (area under the curve 5-6) or cisplatin (75-80 …
WebA Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients With Muscle-Invasive Bladder Cancer WebA Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Gemcitabine+Cisplatin for Neoadjuvant …
WebMar 30, 2024 · Mar 30, 2024. Gina Columbus. The FDA has approved durvalumab for the first-line treatment of adult patients with extensive-stage small cell lung cancer for use in combination with standard-of-care ...
WebDec 4, 2024 · First-line durvalumab plus etoposide with either cisplatin or carboplatin (platinum–etoposide) showed a significant improvement in overall survival versus … camping t shirts ideasWebOct 26, 2024 · Durvalumab group: Cisplatin (75 mg/m² (BSA) D1#) and Etoposide (100 mg/m² (BSA) D1-3) once every 3 weeks for 4-6 cycles and concomitant Radiotherapy (60±6 Gy, 1.8-2 Gy/d with start at latest at beginning of cycle 3, ideally during cycle 1) and additional Durvalumab (1500 mg once every 3 weeks) for 4-6 cycles according to … fischerpfad portugal wandernWebIndicated for first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with etoposide and either carboplatin or cisplatin . Cycles 1-4 in combination with chemotherapy . Each cycle is 21 days; Day 1. Durvalumab 1,500 mg IV (if body weight ; 30 kg, dose at 20 mg/kg IV) PLUS Etoposide 80-100 mg/m 2 IV PLUS fischer pharmaceutical laboratoriesWebMay 30, 2024 · Durvalumab was administered at 1500 mg and tremelimumab was dosed at 75 mg. In all study arms, patients received etoposide at 80 to 100 mg/m² on days 1 to 3 of each 21-day cycle, with investigator’s choice of either carboplatin area under the curve 5 to 6 mg/mL per minute or cisplatin at 75 to 80 mg/m² administered on day 1 of each cycle. 1,4 camping t shirts for kidsWebJun 1, 2024 · After completion of gemcitabine and cisplatin, 1500mg of durvalumab or placebo monotherapy was administered once every 4 weeks until clinical or imaging (per … fischer pharmaceuticalsWebDec 5, 2024 · Rudin CM, Awad MM, Navarro A, et al. Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung … campingturcampingturisterne